Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · Real-Time Price · USD

0.6739

-0.0271 (-3.87%)

At close: May 12, 2025, 4:00 PM

0.6901

+0.0162 (2.40%)

After-hours: May 12, 2025, 5:02 PM EDT

Lexicon Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	31.08	1.2	0.14	0.3	24	Upgrade
Revenue Growth (YoY)	2481.48%	766.19%	-53.36%	-98.76%	-92.55%	Upgrade
Cost of Revenue	84	58.97	52.52	55.05	153.05	Upgrade
Gross Profit	-52.92	-57.77	-52.38	-54.75	-129.06	Upgrade
Selling, General & Admin	131.9	112.54	48.08	32.34	44.23	Upgrade
Operating Expenses	131.9	112.54	48.08	32.34	44.23	Upgrade
Operating Income	-184.82	-170.31	-100.46	-87.09	-173.29	Upgrade
Interest Expense	-15.58	-13.1	-2.78	-0.8	-14.54	Upgrade
Interest & Investment Income	12.29	7.73	1.6	0.13	2.77	Upgrade
EBT Excluding Unusual Items	-188.1	-175.68	-101.64	-87.76	-185.06	Upgrade
Merger & Restructuring Charges	-	-	-	-	-5.5	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	132.59	Upgrade
Asset Writedown	-	-	-	-	-1.6	Upgrade
Other Unusual Items	-12.3	-1.44	-0.3	-	1	Upgrade
Pretax Income	-200.4	-177.12	-101.94	-87.76	-58.57	Upgrade
Net Income	-200.4	-177.12	-101.94	-87.76	-58.57	Upgrade
Net Income to Common	-200.4	-177.12	-101.94	-87.76	-58.57	Upgrade
Shares Outstanding (Basic)	320	221	166	146	111	Upgrade
Shares Outstanding (Diluted)	320	221	166	146	111	Upgrade
Shares Change (YoY)	44.73%	33.42%	13.79%	31.41%	-5.06%	Upgrade
EPS (Basic)	-0.63	-0.80	-0.62	-0.60	-0.53	Upgrade
EPS (Diluted)	-0.63	-0.80	-0.62	-0.60	-0.53	Upgrade
Free Cash Flow	-179.81	-162.37	-90.18	-88.24	-143.06	Upgrade
Free Cash Flow Per Share	-0.56	-0.73	-0.54	-0.61	-1.29	Upgrade
Gross Margin	-170.25%	-	-	-	-	Upgrade
Operating Margin	-594.63%	-14145.35%	-72273.38%	-29224.83%	-722.17%	Upgrade
Profit Margin	-644.78%	-14710.88%	-73341.01%	-29448.99%	-244.11%	Upgrade
Free Cash Flow Margin	-578.52%	-13485.63%	-64875.54%	-29610.07%	-596.19%	Upgrade
EBITDA	-184.28	-169.76	-100.03	-86.8	-170.35	Upgrade
D&A For EBITDA	0.53	0.55	0.43	0.29	2.93	Upgrade
EBIT	-184.82	-170.31	-100.46	-87.09	-173.29	Upgrade
Revenue as Reported	31.08	1.2	0.14	0.3	24	Upgrade

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q